GSK (GSK) announced that Japan’s Ministry of Health, Labour and Welfare, MHLW, has approved a regulatory application to extend the indication of Arexvy for the prevention of RSV disease to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback